This webpage includes links to recent publications and reviews of publications of interest to ASCIA members. 

Reference lists for ASCIA resources are available at https://www.allergy.org.au/hp/papers

Anaphylaxis

Anaphylaxis: emergency management for health professionals - Australian Prescriber wallchart (open access)
www.nps.org.au/australian-prescriber/articles/anaphylaxis-emergency-management-for-health-professionals-update-1

Adrenaline injectors: update on prescribing (open access)
https://medicinetoday.com.au/2022/may/regular-series/adrenaline-injectors-update-prescribing

Changes in Australian food anaphylaxis admission rates following introduction of updated allergy prevention guidelines (open access)
https://linkinghub.elsevier.com/retrieve/pii/S0091674922000811

Food Allergy

Drug (Medication) Allergy

Anaphylaxis in Victoria: presentations to emergency departments, with a focus on drug- and antimicrobial‐related cases (open access)
https://www.mja.com.au/journal/2022/216/10/anaphylaxis-victoria-presentations-emergency-departments-focus-drug-and

Editorial: Drug-induced anaphylaxis in Australia: we need a national drug allergy registry (access restricted to subscribers)
https://onlinelibrary.wiley.com/doi/10.5694/mja2.51527

Reviews of publications 

Immunology Research Review, Issue 5
https://www.researchreview.com.au/au/Clinical-Area/Other-Health/Immunology/Immunology-Research-Review,-Issue-5.aspx

Immunology Research Review Issue 5906.64 KB

Content created May 2022

This webpage includes links to: 

ASCIA Membership Application Form | ASCIA Membership Categories | ASCIA Membership Fees

ASCIA Membership Application Form 

ASCIA is the peak professional body for clinical immunology and allergy in Australia and New Zealand.  

Health professionals are eligible to apply for ASCIA membership if they are actively involved in clinical practice, immunopathology, teaching or research relating to clinical immunology and allergy in Australia and New Zealand. 

Applicants for any ASCIA membership category should not be engaged in commercial activity involving the sale or marketing of allergy and clinical immunology related products, except as an incidental or minor subsidiary activity to clinical practice, teaching or research activities.

ASCIA membership is based on individual membership applications, not group applications, and there are no categories for group or corporate membership.

To apply for ASCIA membership:

1. Email completed application form (as a typed WORD document, not a PDF) to ASCIA - details are on the form.
   ASCIA application form 2024 with type in fields68.29 KB 
2. Do not send any payment with the application, as a Tax Invoice will be emailed once membership is confirmed, after being reviewed at an ASCIA Council meeting, which is held at least four times each year, usually in March, June, September and December.
3. Applications are considered in accordance with the ASCIA Constitution (2015) and By Laws (2019) on the ASCIA website www.allergy.org.au/members/constitution which include specific requirements for ASCIA membership.
4. All ASCIA membership applications require a Full ASCIA member as a sponsor.   

To review ASCIA member services and benefits go to www.allergy.org.au/about-ascia/ascia-initiatives#p1

ASCIA Membership Categories 

ASCIA members must be health professionals or scientists/researchers. They must not be engaged (either personally or on behalf of another person or organisation) in commercial activity involving the sale or marketing of allergy and clinical immunology related products,  except as an incidental or minor subsidiary activity to clinical practice, teaching or research activities.

ASCIA Full Members

(i) Associate – Medical, being persons who are medical practitioners registered for clinical practice in Australia or New Zealand, including persons qualified as general practitioners, or registrars, or with specialist qualifications other than clinical immunology and allergy (e.g. FRACP, FRACS, FRANZCA, FACD);

(ii) Associate – Other Health Professionals, being persons qualified as allied health professionals (e.g. nurses, dietitians, pharmacists). or medical practitioners working in clinical practice overseas;

(iii) Associate – Scientists/Researchers, being persons qualified as scientists or with other relevant qualifications and experience working in a field relevant to clinical immunology and allergy;

(iv) Associate – Trainee, being persons who are advanced trainees in clinical immunology and allergy in Australia or New Zealand; and

(v) Associate – Retired, being persons who were formally members of the company and have retired from clinical practice.

ASCIA Associate members must not be engaged (either personally or on behalf of another person or organisation) in commercial activity involving the sale or marketing of allergy and clinical immunology related products, except as an incidental or minor subsidiary activity to clinical practice, teaching or research activities.

ASCIA Membership Fees

ASCIA Annual Membership Fees for 2024 (AUD including GST) are as follows:

$488 - Full (Ordinary)     

$244 - Associate (Medical Practitioners) 

$196 - Associate (Trainee)

$196 - Associate (Other Health Professionals) 

$196- Associate (Scientist/Researcher)           

$159 - Retired 

These fees will increase by 3% in 2025.

Content updated April 2024

Supply of venom immunotherapy products: honey bee, paper wasp and yellow jacket

December 2018: 

Please find below an update of venom immunotherapy product availability in Australia:

• Honey Bee venom - Hymenoptera Honey Bee venom is in stock
• Paper Wasp venom - A limited quantity of Hymenoptera Paper Wasp venom is now available in Australia. A further shipment has already arrived in Australia and will be available for orders from mid-January 2019.
• Yellow Jacket venom - Hymenoptera Yellow Jacket venom is in stock in Australia

For any further assistance, please contact Stallergenes Greer according to the information set out below:

• For orders or status of orders, please contact DHL on 1800 077 421 or by email at This email address is being protected from spambots. You need JavaScript enabled to view it.
• For medical information enquiries, please contact Dr. Martin Rees (APAC Regional Medical Director) on This email address is being protected from spambots. You need JavaScript enabled to view it.
• To report adverse events, please contact Stallergenes Greer on 1800 824 166 or by email at This email address is being protected from spambots. You need JavaScript enabled to view it.

For guidance on how to make decisions about the appropriate care for patients currently receiving venom immunotherapy, and measures to avoid interruptions to therapy in high-risk patients, you may wish to refer to the:

• ASCIA website members section www.allergy.org.au/members/allergen-immunotherapy
• AAAAI/ACAAI Joint Venom Extract Shortage Task Force Report www.annallergy.org/article/S1081-1206(17)30102-3/fulltext

How to give subcutaneous immunoglobulin (SCIg) infusions

General information for patients (and their parents/carers) giving SCIg infusions at home is available open access on the ASCIA website www.allergy.org.au/hp/papers/immunodeficiency 

The information available on this webpage is specific for SCIg products and devices. 

ASCIA PCC SCIg drawing up Evogam 2017328.03 KB 

ASCIA PCC SCIg drawing up Hizentra 2017272.45 KB 

ASCIA PCC SCIg preparing infusion set butterfly 2017336.68 KB

ASCIA PCC SCIg preparing infusion set butterfly Springfusor 2017.394.00 KB

ASCIA PCC SCIg preparing infusion set high flo 2017310.66 KB

ASCIA PCC SCIg preparing infusion set Neria 2017325.01 KB 

ASCIA PCC SCIg preparing infusion set Neria Springfusor 2017340.35 KB

ASCIA PCC SCIg Springfusor 2017157.61 KB

Content updated October 2020